Schonfeld Strategic Advisors LLC Anavex Life Sciences Corp. Transaction History

Schonfeld Strategic Advisors LLC

  • $13.8 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$6.55 - $9.37 $69,456 - $99,359
10,604 Added 67.61%
26,287 $172,000
Q2 2023

Aug 14, 2023
BUY
$7.66 - $9.5 $120,131 - $148,988
15,683 New
15,683 $127,000
Q3 2022

Nov 14, 2022
BUY
$8.9 - $12.86 $678,589 - $980,523
76,246 Added 453.87%
93,045 $960,000
Q2 2022

Aug 15, 2022
BUY
$7.31 - $12.84 $122,800 - $215,699
16,799 New
16,799 $168,000

Others Institutions Holding AVXL

# of Institutions
155
Shares Held
27.3M
Call Options Held
515K
Put Options Held
838K
View Full List

About ANAVEX LIFE SCIENCES CORP.

AVXL Quotes by TradingView
  • Ticker AVXL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,942,800
  • Market Cap $673M
  • Description
  • Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...
More about AVXL
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email